Literature DB >> 25415172

Bits and pieces: the ethics of uterine morcellation.

Kavita Shah Arora1, Monique Spillman, Magdy Milad.   

Abstract

Intensive media and policy attention has been focused on the ongoing controversy surrounding uterine morcellation in gynecologic surgery. What has been missing from this impassioned discourse is an objective analysis of the ethical implications of uterine power morcellation in gynecologic surgery. This article discusses competing ethical duties of physicians, industry, the U.S. Food and Drug Administration, and the media to develop a more robust and nuanced understanding of informed consent for the use of morcellation in benign gynecologic surgery. Ultimately, as physicians, we must remain steadfast in our dedication to the use of evolving technologies to better patient health in a safe and ethical manner that is well-studied, informed, and implemented with appropriate training and precautions.

Entities:  

Mesh:

Year:  2014        PMID: 25415172     DOI: 10.1097/AOG.0000000000000525

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  1 in total

1.  Hysterectomy for benign conditions: Complications relative to surgical approach and other variables that lead to post-operative readmission within 90 days of surgery.

Authors:  Neal M Lonky; Yasmina Mohan; Vicki Y Chiu; Jeanna Park; Seth Kivnick; Christina Hong; Sharon M Hudson
Journal:  Womens Health (Lond)       Date:  2017-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.